Cargando…

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis

Trachoma, caused by Chlamydia trachomatis (Ct), is the leading infectious blinding disease worldwide. Chronic conjunctival inflammation develops in childhood and leads to eyelid scarring and blindness in adulthood. The immune response to Ct provides only partial protection against re-infection, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Victor H., Holland, Martin J., Burton, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573101/ https://www.ncbi.nlm.nih.gov/pubmed/23457650 http://dx.doi.org/10.1371/journal.pntd.0002020

Ejemplares similares

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Viability PCR shows that non-ocular surfaces could contribute to transmission of Chlamydia trachomatis infection in trachoma
por: Versteeg, Bart, et al.
Publicado: (2020)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia
por: Pickering, Harry, et al.
Publicado: (2020)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes
por: Butcher, Robert, et al.
Publicado: (2017)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Estimating Household and Community Transmission of Ocular Chlamydia trachomatis
por: Blake, Isobel M., et al.
Publicado: (2009)

Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: Identifying potential routes of transmission
por: Last, Anna, et al.
Publicado: (2020)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study
por: Ramadhani, Athumani M., et al.
Publicado: (2017)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity
por: Last, A. R., et al.
Publicado: (2018)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas
por: Derrick, Tamsyn R., et al.
Publicado: (2020)

Evaluation of a Chlamydia trachomatis-specific, commercial, real-time PCR for use with ocular swabs
por: Pickering, Harry, et al.
Publicado: (2018)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease
por: Derrick, Tamsyn, et al.
Publicado: (2017)

Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2022)

Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions
por: Nash, Scott D., et al.
Publicado: (2023)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022)

Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis
por: Butcher, Robert, et al.
Publicado: (2018)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem
por: Senyonjo, Laura G., et al.
Publicado: (2018)

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
por: Burr, Sarah E., et al.
Publicado: (2019)

The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa
por: Last, Anna R., et al.
Publicado: (2017)

Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians
por: Natividad, Angels, et al.
Publicado: (2009)

Immune Protection Against Chlamydia trachomatis in Females
por: Morrison, Richard P.
Publicado: (1996)

A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection
por: Natividad, Angels, et al.
Publicado: (2006)

Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2015)

The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n52ol1go6fo24jfvpu86dghe43